Spinal ependymomas in neurofibromatosis type 2: A retrospective analysis of 55 patients: Clinical article

Journal of Neurosurgery: Spine

Volumn 14, Issue 4, 2011, Pages 543-547

  Plotkin, Scott R ^a   O'Donnell, Caroline C ^a   Curry Jr , William T ^a   Bove, Catherine M ^a   MacCollin, Mia ^a   Nunes, Fabio P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Ependymoma; Natural history; Neurofibromatosis type 2; Spinal cord

Indexed keywords

NEUROFIBROMATOSIS TYPE 2 PROTEIN; NEUROFIBROMIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CERVICAL SPINAL CORD; CHILD; DISEASE ASSOCIATION; EPENDYMOMA; FEMALE; FOLLOW UP; FRAMESHIFT MUTATION; GENERAL HOSPITAL; HOSPITAL PATIENT; HUMAN; LIMB WEAKNESS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MUTATIONAL ANALYSIS; NEUROFIBROMATOSIS; NEUROPATHOLOGY; NONSENSE MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAPLEGIA; POSTOPERATIVE PAIN; QUADRIPLEGIA; RETROSPECTIVE STUDY; SCHOOL CHILD; SPINE SURGERY; SPINE TUMOR; TUMOR GROWTH; TUMOR VOLUME; URINE INCONTINENCE;

ADULT; DISEASE PROGRESSION; EPENDYMOMA; HUMANS; NEUROFIBROMATOSIS 2; RETROSPECTIVE STUDIES; SPINAL CORD NEOPLASMS; TREATMENT OUTCOME;

EID: 79953898836     PISSN: 15475654     EISSN: 15475646     Source Type: Journal    
DOI: 10.3171/2010.11.SPINE10350     Document Type: Article

References (17)

1. Ahronowitz I, Xin W, Kiely R, Sims K, MacCollin M, Nunes FP: Mutational spectrum of the NF2 gene: a meta-analysis of 12 years of research and diagnostic laboratory findings. Hum Mutat 28:1-12, 2007 (Pubitemid 46036208)
2. Baser ME, Friedman JM, Wallace AJ, Ramsden RT, Joe H, Evans DG: Evaluation of clinical diagnostic criteria for neurofibromatosis 2. Neurology 59:1759-1765, 2002 (Pubitemid 35424459)
3. Baser ME, Kuramoto L, Joe H, Friedman JM, Wallace AJ, Gillespie JE, et al: Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a populationbased study. Am J Hum Genet 75:231-239, 2004 (Pubitemid 38943866)
4. Central Brain Tumor Registry of the United States (CBTRUS): Statistical Report: Primary Brain Tumors in the United States, 1998-2002. (http://www.cbtrus.org/reports//2005-2006/2006report.pdf) [Accessed December 7, 2010]
5. Dow G, Biggs N, Evans G, Gillespie J, Ramsden R, King A: Spinal tumors in neurofibromatosis type 2. Is emerging knowledge of genotype predictive of natural history? J Neurosurg Spine 2:574-579, 2005
6. Evans DG, Huson SM, Donnai D, Neary W, Blair V, Newton V, et al: A clinical study of type 2 neurofibromatosis. Q J Med 84:603-618, 1992 (Pubitemid 23007763)
7. Gilhuis HJ, van der Laak J, Wesseling P, Boerman RH, Beute G, Teepen JL, et al: Inverse correlation between genetic aberrations and malignancy grade in ependymal tumors: a paradox? J Neurooncol 66:111-116, 2004 (Pubitemid 38258365)
8. Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, et al: The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51-57, 1997 (Pubitemid 27274517)
9. Jacoby LB, Jones D, Davis K, Kronn D, Short MP, Gusella J, et al: Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis. Am J Hum Genet 61:1293-1302, 1997 (Pubitemid 28046905)
10. Kobata H, Kuroiwa T, Isono N, Nagasawa S, Ohta T, Tsutsumi A: Tanycytic ependymoma in association with neurofibromatosis type 2. Clin Neuropathol 20:93-100, 2001 (Pubitemid 32476339)
11. Mautner VF, Tatagiba M, Lindenau M, Fünsterer C, Pulst SM, Baser ME, et al: Spinal tumors in patients with neurofibromatosis type 2: MR imaging study of frequency, multiplicity, and variety. AJR Am J Roentgenol 165:951-955, 1995
12. Miyazawa N, Hida K, Iwasaki Y, Koyanagi I, Abe H: MRI at 1.5 T of intramedullary ependymoma and classification of pattern of contrast enhancement. Neuroradiology 42:828-832, 2000
13. Patronas NJ, Courcoutsakis N, Bromley CM, Katzman GL, MacCollin M, Parry DM: Intramedullary and spinal canal tumors in patients with neurofibromatosis 2: MR imaging findings and correlation with genotype. Radiology 218:434-442, 2001 (Pubitemid 32121056)
14. Rennie AT, Side L, Kerr RS, Anslow P, Pretorius P: Intramedullary tumours in patients with neurofibromatosis type 2: MRI features associated with a favourable prognosis. Clin Radiol 63:193-200, 2008
15. Schwartz TH, McCormick PC: Intramedullary ependymomas: clinical presentation, surgical treatment strategies and prognosis. J Neurooncol 47:211-218, 2000
16. Sun B, Wang C, Wang J, Liu A: MRI features of intramedullary spinal cord ependymomas. J Neuroimaging 13:346-351, 2003 (Pubitemid 37159022)
17. Ueki K, Sasaki T, Ishida T, Kirino T: Spinal tanycytic ependymoma associated with neurofibromatosis type 2-case report. Neurol Med Chir (Tokyo) 41:513-516, 2001 (Pubitemid 33027200)